admin

LINCOLN — Most patients with severe forms of epilepsy who’ve been taking a marijuana-derived drug at the University of Nebraska Medical Center continue to see improvement in their seizures. A majority of the 23 patients who’ve remained in a two-year clinical trial have experienced benefits from taking purified cannabidiol, or CBD oil, that’s supplied to […]

by

CBD oil. (Credit: ELRoi/Shutterstock) One of the most controversial drugs in America can’t even get you high. Derived from marijuana, CBD, or cannabidiol, could help treat a range of medical conditions, early research suggests — but its Schedule I status has made it hard to study, leaving researchers and patients in the dark. Although it’s […]

by

After just three days taking a few tiny drops of a medicinal cannabis oil product, Danny Battershill says his life has changed. The 29-year-old Rodney resident has gained medical approval to trial a legally imported Canadian product, after proving that other medications for his chronic eczema no longer work. He says treatments such as steroids, […]

by

In June, for the first time, The Food and Drug Administration  approved a plant-derived medicine from marijuana. The prescription drug, known as Epidiolex, contains a proprietary formulation of cannabis’ organic compounds — primarily cannabidiol (CBD) —for the treatment of severe seizure disorders. The British pharmaceutical company — the manufacturer of the drug — a has […]

by

With more states in the U.S. legalizing marijuana to varying levels, the drug is entering the mainstream. Naturally, that’s left a lot of investors wondering: How can I make money investing in marijuana? In this episode of The Motley Fool’s Industry Focus: Healthcare, analyst Kristine Harjes and Motley Fool contributor Todd Campbell discuss: The difference between […]

by

With more states in the U.S. legalizing marijuana to varying levels, the drug is entering the mainstream. Naturally, that’s left a lot of investors wondering: How can I make money investing in marijuana? In this episode of The Motley Fool’s Industry Focus: Healthcare, analyst Kristine Harjes and Motley Fool contributor Todd Campbell discuss: The difference between […]

by

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced the introduction of RELICANN™, the Company’s hemp-based  and medical cannabis brand designed for the health and wellness […]

by

CBD can be taken in a few ways. Oil is probably the most popular, but it can also be taken in capsule form, or even as a chocolate or gummy. After a week of taking CBD in oil form every night, it was clear I’d stumbled across something kind of remarkable. I often slept well […]

by

Posted: Tuesday, September 11, 2018 7:01 am Tilray® Exports 2:100 CBD Oil to the United Kingdom Associated Press | NANAIMO, British Columbia–(BUSINESS WIRE)–Sep 11, 2018–Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed,… read more at: https://www.oaoa.com/news/business/article_f19de45a-645c-55e9-ad8c-262f731706ee.html

by

Endexx Corporation (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, has announced its investment in EcoHealth Neuropathy, Inc., an Arizona-based corporation, to launch its platform for clinical and technology driven management of neuropathies. EcoHealth Neuropathy Inc., a full-service healthcare provider for the treatment of diabetic neuropathy will be led by Dr. […]

by

Tilray announced the successful import of its Tilray 2:100 product into the United Kingdom. Tilray (NASDAQ:TLRY) announced the successful import of its Tilray 2:100 cannabidiol (CBD) oil product into the UK to supply a pediatric patient. As quoted in the press release: The changing regulatory measures in the United Kingdom (UK) previously prohibited the use of medical cannabis. However, […]

by

TORONTO – September 11, 2018 (Investorideas.com Newswire) Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced the introduction of RELICANN™, the Company’s hemp-based and medical cannabis brand designed for the health and wellness […]

by

NANAIMO, British Columbia — Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need. The changing regulatory measures in the […]

by

No media source currently available Pop-out player British scientists have found how a substance in the cannabis plant acts in the brain to reduce abnormal activity in patients at risk of psychosis. Their findings suggest that the substance could be used in a possible treatment for the condition. Cannabis, also known as marijuana, is illegal […]

by